Bank Of America Corp In8 Bio, Inc. Transaction History
Bank Of America Corp
- $1.21 Trillion
- Q1 2025
A detailed history of Bank Of America Corp transactions in In8 Bio, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 485 shares of INAB stock, worth $67. This represents 0.0% of its overall portfolio holdings.
Number of Shares
485
Previous 460
5.43%
Holding current value
$67
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding INAB
# of Institutions
29Shares Held
21.7MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX8.6MShares$1.2 Million1.8% of portfolio
-
Franklin Resources Inc San Mateo, CA5.7MShares$797,4680.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL2.08MShares$291,1400.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$252,4130.0% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.45MShares$203,0000.13% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $3.43M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...